AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32645771 — intervention group
Group type: COMPARATOR
Intervention: Placebo administration during cardiopulmonary bypass (CPB)
Number of subjects: 24
Study 35255184 — intervention group
Group type: EXPERIMENTAL
Intervention: Shockwave therapy
Number of subjects: 30
Study 35255184 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency
Number of subjects: 30
Study 35255184 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 32967704 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous vagus nerve stimulation (Nemos® tVNS), sham-controlled
Number of subjects: 112
Study 32967704 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational nondirective resonance breathing (MNRB™), sham-controlled
Number of subjects: 112
Study 33935227 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Advocacy for Independent Life (SAIL) intervention
Number of subjects: 67
Study 33935227 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 67
Study 34083615 — intervention group
Group type: EXPERIMENTAL
Intervention: Anfibatide administered intravenously as a single dose bolus or a bolus followed by a constant rate infusion for 24 hours
Number of subjects: 94
Study 34083615 — intervention group
Group type: EXPERIMENTAL
Intervention: Anfibatide
Number of subjects: 94
Study 34920734 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 75 mg once-daily
Number of subjects: 96
Study 34920734 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 300 mg once-daily
Number of subjects: 96
Study 34920734 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 96
Study 34920734 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA1c levels > 65 mmol/mol
Number of subjects: 96
Study 34920734 — intervention group
Group type: EXPERIMENTAL
Intervention: HbA1c levels > 70 mmol/mol
Number of subjects: 96
Study 34920734 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher HbA1c
Number of subjects: 96
Study 33501530 — intervention group
Group type: EXPERIMENTAL
Intervention: Full‐day leadership training retreat for team leaders to facilitate care team huddles, biweekly coaching calls, and two site visits with an assigned coach.
Number of subjects: 29
Study 33501530 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher adherence to the intervention within the intervention group.
Number of subjects: 29
Study 33501530 — intervention group
Group type: COMPARATOR
Intervention: Routine practice (control group).
Number of subjects: 29
Study 36605352 — intervention group
Group type: EXPERIMENTAL
Intervention: Barbed sutures
Number of subjects: 60
Study 36605352 — intervention group
Group type: COMPARATOR
Intervention: Tackers with transfacial sutures
Number of subjects: 60
Study 33035194 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic pain and physical activity training workshop
Number of subjects: 48
Study 32328239 — intervention group
Group type: EXPERIMENTAL
Intervention: Waist:Hip Ratio (WHR)
Number of subjects: 1709
Study 32328239 — intervention group
Group type: EXPERIMENTAL
Intervention: Waist:Height Ratio (WHtR)
Number of subjects: 1709
Study 32328239 — intervention group
Group type: EXPERIMENTAL
Intervention: Waist Circumference (WC)
Number of subjects: 1709
Study 32328239 — intervention group
Group type: COMPARATOR
Intervention: Body Mass Index (BMI)
Number of subjects: 1709
Study 32328239 — intervention group
Group type: COMPARATOR
Intervention: Body Fat Percentage and Fat per Square of Height
Number of subjects: 1709
Study 36437191 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined model incorporating clinical and PET features
Number of subjects: 271
Study 36437191 — intervention group
Group type: COMPARATOR
Intervention: International Prognostic Index (IPI) model
Number of subjects: 271
Study 36437191 — intervention group
Group type: COMPARATOR
Intervention: Best baseline clinical model
Number of subjects: 271
Study 36437191 — intervention group
Group type: COMPARATOR
Intervention: Deauville score (DS) model
Number of subjects: 271
Study 36437191 — intervention group
Group type: COMPARATOR
Intervention: Best combined clinical model
Number of subjects: 271
Study 36437191 — intervention group
Group type: COMPARATOR
Intervention: Best PET-based radiomics model
Number of subjects: 271
Study 33125609 — intervention group
Group type: EXPERIMENTAL
Intervention: Real tDCS
Number of subjects: 24
Study 33125609 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 24
Study 33541060 — intervention group
Group type: EXPERIMENTAL
Intervention: Sander bite jumping appliance (BJA)
Number of subjects: 20
Study 33541060 — intervention group
Group type: COMPARATOR
Intervention: Andresen activator (AA)
Number of subjects: 20
Study 36131360 — intervention group
Group type: COMPARATOR
Intervention: Febuxostat 80 mg alone
Number of subjects: 0
Study 36131360 — intervention group
Group type: COMPARATOR
Intervention: SHR4640 10 mg alone
Number of subjects: 0
Study 36131360 — intervention group
Group type: EXPERIMENTAL
Intervention: SHR4640 combined with febuxostat
Number of subjects: 0
Study 34837937 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-notification of the request for further information, sent 1 day before the request.
Number of subjects: 75
Study 34837937 — intervention group
Group type: COMPARATOR
Intervention: Control group (no pre-notification).
Number of subjects: 75
Study 34970224 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Carbohydrate Diet (LCD)
Number of subjects: 134
Study 34970224 — intervention group
Group type: COMPARATOR
Intervention: Low-Fat Diet (LFD)
Number of subjects: 134
Study 32114867 — intervention group
Group type: EXPERIMENTAL
Intervention: Training given to parents (5-week duration)
Number of subjects: 75
Study 32114867 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 75
Study 33992100 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal manual therapy
Number of subjects: 43
Study 33992100 — intervention group
Group type: COMPARATOR
Intervention: Local exercise therapy
Number of subjects: 43
Study 32897437 — intervention group
Group type: EXPERIMENTAL
Intervention: HES 130/0.4/9
Number of subjects: 50
Study 32897437 — intervention group
Group type: COMPARATOR
Intervention: 5% albumin
Number of subjects: 50
Study 34472676 — intervention group
Group type: EXPERIMENTAL
Intervention: WEB+TXT (n=311)
Number of subjects: 618
Study 34472676 — intervention group
Group type: COMPARATOR
Intervention: WEB (n=307)
Number of subjects: 618
Study 34472676 — intervention group
Group type: EXPERIMENTAL
Intervention: WEB+TXT
Number of subjects: 618
Study 33856430 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 377
Study 33856430 — intervention group
Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 377
Study 32321172 — intervention group
Group type: EXPERIMENTAL
Intervention: Antithrombin (AT) supplementation
Number of subjects: 784
Study 32321172 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibrinogen concentrates
Number of subjects: 784
Study 32321172 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh frozen plasma transfusion
Number of subjects: 784
Study 32321172 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin prophylaxis
Number of subjects: 784
Study 32321172 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic measures
Number of subjects: 784
Study 32321172 — intervention group
Group type: EXPERIMENTAL
Intervention: L‐asparaginase (L‐ASP) therapy
Number of subjects: 784
Study 32321172 — intervention group
Group type: EXPERIMENTAL
Intervention: L‐ASP reintroduction
Number of subjects: 784
Study 35287591 — intervention group
Group type: EXPERIMENTAL
Intervention: sintilimab immunotherapy combined with XELOX chemotherapy
Number of subjects: 30
Study 33559248 — intervention group
Group type: EXPERIMENTAL
Intervention: Completion of Donor Health Questionnaire (DHQ) and antibody testing
Number of subjects: 521
Study 33559248 — intervention group
Group type: EXPERIMENTAL
Intervention: PCR testing for SARS-CoV-2
Number of subjects: 521
Study 33559248 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibody testing
Number of subjects: 521
Study 33559248 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall screening process
Number of subjects: 521
Study 32922193 — intervention group
Group type: EXPERIMENTAL
Intervention: Ephedrine 20 mg intramuscularly
Number of subjects: 116
Study 32922193 — intervention group
Group type: COMPARATOR
Intervention: 0.9% NaCl (saline)
Number of subjects: 116
Study 34779837 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality improvement intervention bundle including educational materials, clinical algorithm and order set for IVF use, electronic medical record interventions, and 'harms of overtesting' cards.
Number of subjects: 100
Study 34779837 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality improvement intervention bundle
Number of subjects: 100
Study 35010414 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness- and compassion-based program (MCBP for University Life)
Number of subjects: 30
Study 35010414 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 30
Study 36026840 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril 10 mg once daily
Number of subjects: 146
Study 36026840 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine gastrointestinal therapeutic system (GITS) 30 mg once daily
Number of subjects: 146
Study 36026840 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 146
Study 33514760 — intervention group
Group type: EXPERIMENTAL
Intervention: RRR‐α‐tocopherol (ALC) at doses of 50, 75, 100, and 150 mg/kg of diet
Number of subjects: 168
Study 33514760 — intervention group
Group type: EXPERIMENTAL
Intervention: RRR‐α‐tocopheryl acetate (ACT)
Number of subjects: 168
Study 33514760 — intervention group
Group type: EXPERIMENTAL
Intervention: all‐rac‐α‐tocopheryl acetate (SYN)
Number of subjects: 168
Study 33514760 — intervention group
Group type: COMPARATOR
Intervention: No added α‐tocopherol in the feed (0 dose)
Number of subjects: 168
Study 34954095 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (daily HCQ)
Number of subjects: 624
Study 34954095 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (weekly HCQ)
Number of subjects: 624
Study 34954095 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 624
Study 35902796 — intervention group
Group type: EXPERIMENTAL
Intervention: Eptinezumab 100 mg
Number of subjects: 238
Study 35902796 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 238
Study 33394005 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat vegan diet
Number of subjects: 0
Study 33394005 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 32493624 — intervention group
Group type: EXPERIMENTAL
Intervention: Tungsten carbide bur
Number of subjects: 28
Study 32493624 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibreglass bur
Number of subjects: 28
Study 32493624 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymer bur
Number of subjects: 28
Study 32493624 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymer bur with 75% ethanol pre-treatment
Number of subjects: 28
Study 32493624 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymer burs
Number of subjects: 28
Study 36219925 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory muscle training (RMT) with a threshold resistance device, daily, twice a day for three sets of 15 repetitions for 8 weeks
Number of subjects: 36
Study 36219925 — intervention group
Group type: COMPARATOR
Intervention: Control group (lifestyle modification education without RMT)
Number of subjects: 36
Study 33761976 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA)
Number of subjects: 42
Study 33761976 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard active rehabilitation)
Number of subjects: 42
Study 32192925 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium-prepared platelet-rich fibrin (T-PRF)
Number of subjects: 30
Study 32192925 — intervention group
Group type: COMPARATOR
Intervention: Connective tissue graft (CTG)
Number of subjects: 30
Study 32192925 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 30
Study 35636174 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-administered pediatric tuina
Number of subjects: 64
Study 35636174 — intervention group
Group type: COMPARATOR
Intervention: Parent–child interaction group (control)
Number of subjects: 64
Study 32526188 — intervention group
Group type: EXPERIMENTAL
Intervention: Trivalent inactivated influenza vaccine (IIV)
Number of subjects: 10002
Study 32526188 — intervention group
Group type: COMPARATOR
Intervention: Saline placebo (Control)
Number of subjects: 10002
Study 32526188 — intervention group
Group type: COMPARATOR
Intervention: Quadrivalent meningococcal conjugate vaccine (Control)
Number of subjects: 10002
Study 33688020 — intervention group
Group type: EXPERIMENTAL
Intervention: RT + anti-PD-L1 + L19-IL2
Number of subjects: 0
Study 33688020 — intervention group
Group type: EXPERIMENTAL
Intervention: RT + L19-IL2
Number of subjects: 0
Study 33688020 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple combinations (RT + anti-PD-L1 + L19-IL2)
Number of subjects: 0
Study 33688020 — intervention group
Group type: COMPARATOR
Intervention: RT + anti-PD-L1
Number of subjects: 0
Study 32414580 — intervention group
Group type: EXPERIMENTAL
Intervention: IV glibenclamide
Number of subjects: 77
Study 32414580 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77
Study 32414580 — intervention group
Group type: EXPERIMENTAL
Intervention: Osmotherapy
Number of subjects: 77
Study 616062859 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitosis Kinase Score (MKS) assessed at surgery
Number of subjects: 417
Study 616062859 — intervention group
Group type: EXPERIMENTAL
Intervention: p21 expression at surgery
Number of subjects: 417
Study 616062859 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of MKS and p21
Number of subjects: 417
Study 36435551 — intervention group
Group type: EXPERIMENTAL
Intervention: Instrumental behavior providing 100% contingency information about aversive or neutral events
Number of subjects: 0
Study 36435551 — intervention group
Group type: COMPARATOR
Intervention: Instrumental behavior providing 50% contingency information
Number of subjects: 0
Study 34554308 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramedullary nailing (IMN)
Number of subjects: 99
Study 34554308 — intervention group
Group type: COMPARATOR
Intervention: Locking plate (LP)
Number of subjects: 99
Study 32469922 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Navigator programme over six months in addition to routine care (n = 30)
Number of subjects: 40
Study 32469922 — intervention group
Group type: COMPARATOR
Intervention: Routine care (n = 10)
Number of subjects: 40
Study 35835904 — intervention group
Group type: EXPERIMENTAL
Intervention: Oncofertility education based on the naturalistic decision-making (NDM) model
Number of subjects: 84
Study 35835904 — intervention group
Group type: COMPARATOR
Intervention: Non-oncofertility education
Number of subjects: 84
Study 32840151 — intervention group
Group type: EXPERIMENTAL
Intervention: Honey
Number of subjects: 0
Study 32840151 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 36221141 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive Digital Marker (PDM)
Number of subjects: 7200
Study 36221141 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive Digital Marker (PDM) with Quick Dementia Rating Scale (QDRS)
Number of subjects: 7200
Study 36221141 — intervention group
Group type: COMPARATOR
Intervention: Neither intervention (control group)
Number of subjects: 7200
Study 33528063 — intervention group
Group type: EXPERIMENTAL
Intervention: First-line treatments (various types including chemotherapy and radiotherapy)
Number of subjects: 85
Study 33528063 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 85
Study 33528063 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy (CH) and radiotherapy (RT)
Number of subjects: 85
Study 33528063 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT)
Number of subjects: 85
Study 33528063 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy (CH) only
Number of subjects: 85
Study 33528063 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall cohort
Number of subjects: 85
Study 33528063 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage IV patients
Number of subjects: 85
Study 32019488 — intervention group
Group type: EXPERIMENTAL
Intervention: Low pressure pneumoperitoneum (8 mmHg)
Number of subjects: 44
Study 32019488 — intervention group
Group type: COMPARATOR
Intervention: Standard pressure pneumoperitoneum (12 mmHg)
Number of subjects: 44
Study 35226083 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with doxorubicin, cyclophosphamide, and paclitaxel plus bevacizumab
Number of subjects: 519
Study 35226083 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant chemotherapy with doxorubicin, cyclophosphamide, and paclitaxel plus placebo
Number of subjects: 519
Study 35226083 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with doxorubicin, cyclophosphamide, and paclitaxel (group C)
Number of subjects: 519
Study 35226083 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 519
Study 35226083 — intervention group
Group type: EXPERIMENTAL
Intervention: Mastectomy with radiation
Number of subjects: 519
Study 35226083 — intervention group
Group type: EXPERIMENTAL
Intervention: Asian, Black, or American Indian or Alaska Native race
Number of subjects: 519
Study 33754828 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning-based detection (DLD) system
Number of subjects: 228
Study 33754828 — intervention group
Group type: COMPARATOR
Intervention: Pooled observers
Number of subjects: 228
Study 35610625 — intervention group
Group type: EXPERIMENTAL
Intervention: Elian Granules (24.2 g, two small bags, twice a day for 24 weeks)
Number of subjects: 240
Study 35610625 — intervention group
Group type: COMPARATOR
Intervention: Placebo (two small bags, twice a day for 24 weeks)
Number of subjects: 240
Study 32557000 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (fractional 2940-nm Er:YAG laser + 5% amorolfine lacquer)
Number of subjects: 0
Study 32557000 — intervention group
Group type: COMPARATOR
Intervention: Monotherapy (5% amorolfine lacquer)
Number of subjects: 0
Study 35266202 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumatic jet injection (PJI) with 5-fluorouracil (5-FU) and triamcinolone acetonide (TAC)
Number of subjects: 20
Study 35266202 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 20
Study 35266202 — intervention group
Group type: EXPERIMENTAL
Intervention: PJI with TAC + 5-FU
Number of subjects: 20
Study 33004742 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI-guided microwave ablation (MWA)
Number of subjects: 43
Study 33004742 — intervention group
Group type: COMPARATOR
Intervention: CT-guided microwave ablation (MWA)
Number of subjects: 43
Study 34021767 — intervention group
Group type: EXPERIMENTAL
Intervention: High Level of Confidence (LOC)
Number of subjects: 250
Study 34021767 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate Level of Confidence (LOC)
Number of subjects: 250
Study 34021767 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Level of Confidence (LOC)
Number of subjects: 250
Study 34021767 — intervention group
Group type: EXPERIMENTAL
Intervention: Critically Low Level of Confidence (LOC)
Number of subjects: 250
Study 34021767 — intervention group
Group type: EXPERIMENTAL
Intervention: Consort Adherence Score (CAS)
Number of subjects: 250
Study 33225808 — intervention group
Group type: EXPERIMENTAL
Intervention: MRT (modified rolling hitch with tape)
Number of subjects: 40
Study 33225808 — intervention group
Group type: COMPARATOR
Intervention: MRS (modified rolling hitch with suture)
Number of subjects: 40
Study 33225808 — intervention group
Group type: COMPARATOR
Intervention: MPS (modified Prusik knot with suture)
Number of subjects: 40
Study 33225808 — intervention group
Group type: COMPARATOR
Intervention: MPT (modified Prusik knot with tape)
Number of subjects: 40
Study 32615777 — intervention group
Group type: EXPERIMENTAL
Intervention: Cookstove air pollution exposure
Number of subjects: 48
Study 32615777 — intervention group
Group type: COMPARATOR
Intervention: Filtered-air control
Number of subjects: 48
Study 33430955 — intervention group
Group type: COMPARATOR
Intervention: COAST only
Number of subjects: 0
Study 33430955 — intervention group
Group type: EXPERIMENTAL
Intervention: COAST plus external facilitation (EF)
Number of subjects: 0
Study 33430955 — intervention group
Group type: EXPERIMENTAL
Intervention: COAST plus EF and internal facilitation (EF/IF)
Number of subjects: 0
Study 34686629 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioceptive neuromuscular facilitation stretching
Number of subjects: 36
Study 34686629 — intervention group
Group type: COMPARATOR
Intervention: Health lecture series (Control)
Number of subjects: 36
Study 32552310 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative approach to public health communication
Number of subjects: 0
Study 32552310 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrative detailing a description of the evidence delivered by a healthcare professional
Number of subjects: 0
Study 33499847 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg/kg ART (ig) treatment diabetic
Number of subjects: 40
Study 33499847 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg/kg ART (ig) treatment diabetic
Number of subjects: 40
Study 33499847 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 U/kg insulin (iH) treatment diabetic
Number of subjects: 40
Study 33499847 — intervention group
Group type: COMPARATOR
Intervention: Diabetic control group
Number of subjects: 40
Study 33761461 — intervention group
Group type: EXPERIMENTAL
Intervention: High-load (HL) half-squat priming (87% 1RM)
Number of subjects: 15
Study 33761461 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-load (ML) half-squat priming (65% 1RM)
Number of subjects: 15
Study 33761461 — intervention group
Group type: COMPARATOR
Intervention: Control activity
Number of subjects: 15
Study 32567238 — intervention group
Group type: EXPERIMENTAL
Intervention: YiqiFumai lyophilized injection (5.2 g/day)
Number of subjects: 1270
Study 32567238 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1270
Study 33219590 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry topical heat for 7 min using two hot seed bags (N=21)
Number of subjects: 59